NSEI:RPGLIFE

Stock Analysis Report

NOT FOR DISTRIBUTION
Header cover image

Executive Summary

RPG Life Sciences Limited, an integrated pharmaceutical company, develops, manufactures, and markets branded formulations, generic, and synthetic active pharmaceutical ingredients (APIs) in India and internationally. More Details


Snowflake Analysis

Flawless balance sheet with proven track record.

Share Price & News

How has RPG Life Sciences's share price performed over time and what events caused price changes?


Latest Share Price and Events

Stable Share Price: RPGLIFE is not significantly more volatile than the rest of Indian stocks over the past 3 months, typically moving +/- 6% a week.

Volatility Over Time: RPGLIFE's weekly volatility (6%) has been stable over the past year.


Market Performance


7 Day Return

4.4%

RPGLIFE

2.3%

IN Pharmaceuticals

2.1%

IN Market


1 Year Return

35.0%

RPGLIFE

45.0%

IN Pharmaceuticals

7.0%

IN Market

Return vs Industry: RPGLIFE underperformed the Indian Pharmaceuticals industry which returned 45% over the past year.

Return vs Market: RPGLIFE exceeded the Indian Market which returned 7% over the past year.


Shareholder returns

RPGLIFEIndustryMarket
7 Day4.4%2.3%2.1%
30 Day3.6%1.2%9.1%
90 Day-1.8%0.9%9.3%
1 Year38.7%35.0%46.7%45.0%9.0%7.0%
3 Year-15.9%-19.8%37.6%34.3%6.7%1.5%
5 Year17.0%10.0%9.2%5.4%53.5%42.0%

Long-Term Price Volatility Vs. Market

How volatile is RPG Life Sciences's share price compared to the market and industry in the last 5 years?


Simply Wall St News

Valuation

Is RPG Life Sciences undervalued compared to its fair value and its price relative to the market?

19.2x

Price to Earnings (PE) ratio


Share Price vs. Fair Value

Below Fair Value: RPGLIFE (₹363.25) is trading above our estimate of fair value (₹114.09)

Significantly Below Fair Value: RPGLIFE is trading above our estimate of fair value.


Price To Earnings Ratio

PE vs Industry: RPGLIFE is good value based on its PE Ratio (19.2x) compared to the IN Pharmaceuticals industry average (21.8x).

PE vs Market: RPGLIFE is poor value based on its PE Ratio (19.2x) compared to the Indian market (17.1x).


Price to Earnings Growth Ratio

PEG Ratio: Insufficient data to calculate RPGLIFE's PEG Ratio to determine if it is good value.


Price to Book Ratio

PB vs Industry: RPGLIFE is overvalued based on its PB Ratio (3x) compared to the IN Pharmaceuticals industry average (2.2x).


Next Steps

Future Growth

How is RPG Life Sciences forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?

21.5%

Forecasted Pharmaceuticals & Biotech industry annual growth in earnings


In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as RPG Life Sciences has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.


Next Steps

Past Performance

How has RPG Life Sciences performed over the past 5 years?

15.7%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: RPGLIFE has high quality earnings.

Growing Profit Margin: RPGLIFE's current net profit margins (8.4%) are higher than last year (7.1%).


Past Earnings Growth Analysis

Earnings Trend: RPGLIFE's earnings have grown by 15.7% per year over the past 5 years.

Accelerating Growth: RPGLIFE's earnings growth over the past year (24.6%) exceeds its 5-year average (15.7% per year).

Earnings vs Industry: RPGLIFE earnings growth over the past year (24.6%) underperformed the Pharmaceuticals industry 24.6%.


Return on Equity

High ROE: RPGLIFE's Return on Equity (15.8%) is considered low.


Next Steps

Financial Health

How is RPG Life Sciences's financial position?


Financial Position Analysis

Short Term Liabilities: RPGLIFE's short term assets (₹1.5B) exceed its short term liabilities (₹774.5M).

Long Term Liabilities: RPGLIFE's short term assets (₹1.5B) exceed its long term liabilities (₹72.0M).


Debt to Equity History and Analysis

Debt Level: RPGLIFE is debt free.

Reducing Debt: RPGLIFE has no debt compared to 5 years ago when its debt to equity ratio was 22.6%.

Debt Coverage: RPGLIFE has no debt, therefore it does not need to be covered by operating cash flow.

Interest Coverage: RPGLIFE has no debt, therefore coverage of interest payments is not a concern.


Balance Sheet


Next Steps

Dividend

What is RPG Life Sciences's current dividend yield, its reliability and sustainability?

1.11%

Current Dividend Yield


Dividend Yield vs Market

Notable Dividend: RPGLIFE's dividend (1.11%) is higher than the bottom 25% of dividend payers in the Indian market (0.54%).

High Dividend: RPGLIFE's dividend (1.11%) is low compared to the top 25% of dividend payers in the Indian market (2.14%).


Stability and Growth of Payments

Stable Dividend: RPGLIFE's dividend payments have been volatile in the past 10 years.

Growing Dividend: RPGLIFE's dividend payments have increased over the past 10 years.


Current Payout to Shareholders

Dividend Coverage: Unable to calculate sustainability of dividends as RPGLIFE has not reported any payouts.


Future Payout to Shareholders

Future Dividend Coverage: Insufficient data to determine if a dividend will be paid in 3 years and that it will be covered by earnings.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

3.6yrs

Average management tenure


CEO

Yugal Kishor Sikri (63 yo)

2.08yrs

Tenure

₹22,075,328

Compensation

Mr. Yugal Kishor Choturam Sikri has been Managing Director and Additional Director at RPG Life Sciences Limited since October 1, 2018 .He served as an Independent & Non-Executive Director at RPG Life Scien...


CEO Compensation Analysis

Compensation vs Market: Yugal Kishor's total compensation ($USD0.00) is below average for companies of similar size in the Indian market ($USD50.36K).

Compensation vs Earnings: Yugal Kishor's compensation has increased by more than 20% in the past year.


Leadership Team

NamePositionTenureCompensationOwnership
Yugal Kishor Sikri
MD & Additional Director2.08yrs₹22.08m0.21%
₹ 12.8m
Vishal Shah
Chief Financial Officer0.25yrno datano data
Ramanathan Varadarajan
Chief Operating Officer0.67yrno datano data
Rajesh Shirambekar
Head of Legal9yrsno datano data
Tushar Joshi
Head of Human Resources4.17yrsno datano data
Suchitra Tiwari
Head of Regulatory & Project Managementno datano datano data
B. Sundaram
Business Head of API - International & Specialty5.17yrsno datano data
Himmat Patel
Head of Domestic Manufacturing & Sourcing3.58yrsno datano data
Kartick Patra
Head of API Operations & Procurement3.58yrsno datano data
Rajesh Chopra
Site Head of International Formulationno datano datano data
Milind Gujar
Chief Quality Officer1.83yrsno datano data
Samir Rane
Business Unit Head of Domestic Formulationsno datano datano data

3.6yrs

Average Tenure

Experienced Management: RPGLIFE's management team is considered experienced (3.6 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Yugal Kishor Sikri
MD & Additional Director2.08yrs₹22.08m0.21%
₹ 12.8m
Lalit Kanodia
Independent & Non-Executive Director12.75yrs₹615.00kno data
Harsh Goenka
Chairman of the Boardno data₹600.00k0.16%
₹ 9.7m
Manojkumar Maheshwari
Independent & Non-Executive Director16.33yrs₹600.00kno data
Mahesh Gupta
Independent & Non-Executive Director17.08yrs₹704.00kno data
Narendra Ambwani
Independent & Non-Executive Director6.33yrs₹664.00k0.0060%
₹ 361.2k
Sachin Nandgaonkar
Non-Executive Director5.83yrs₹815.00k0.046%
₹ 2.7m
Zahabiya Khorakiwala
Independent & Non-Executive Director5.08yrs₹410.00kno data
Bhaskar Iyer
Independent Non-Executive Directorno datano datano data

6.3yrs

Average Tenure

63yo

Average Age

Experienced Board: RPGLIFE's board of directors are considered experienced (6.3 years average tenure).


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Company Information

RPG Life Sciences Limited's company bio, employee growth, exchange listings and data sources


Key Information

  • Name: RPG Life Sciences Limited
  • Ticker: RPGLIFE
  • Exchange: NSEI
  • Founded: 1968
  • Industry: Pharmaceuticals
  • Sector: Pharmaceuticals & Biotech
  • Market Cap: ₹5.970b
  • Shares outstanding: 16.54m
  • Website: https://www.rpglifesciences.com

Number of Employees


Location

  • RPG Life Sciences Limited
  • RPG HOUSE
  • 463, Dr. Annie Besant Road
  • Mumbai
  • Maharashtra
  • 400030
  • India

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
532983BSE (Mumbai Stock Exchange)YesEquity SharesININRJun 2008
RPGLIFENSEI (National Stock Exchange of India)YesEquity SharesININRJun 2008

Biography

RPG Life Sciences Limited, an integrated pharmaceutical company, develops, manufactures, and markets branded formulations, generic, and synthetic active pharmaceutical ingredients (APIs) in India and inter...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2020/11/27 12:08
End of Day Share Price2020/11/27 00:00
Earnings2020/09/30
Annual Earnings2020/03/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.